Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Patterns of Undertreatment Among Patients with Acute Myeloid Leukemia (AML) Not Receiving Standard Intensive Induction Chemotherapy

Elizabeth Hubscher, Slaven Sikirica, Timothy J. Bell, Andrew Brown, PhD, Verna L Welch, PhD MPH, Alexander Russell-Smith, MSc, Paul G D'Amico, PhDRN,NP

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137425

Published: 2020

Journal Articles

Treatment Decision Making in AML: Factors of Importance to Clinicians, AML Patients and Their Family

Thomas W. LeBlanc, MDMA,MHS, Roland B. Walter, MD PhD MS, Loriana Hernandez-Aldama, Kate Sully, PhD, Timothy J Bell, MHA, Chloe Johnson, Francois Peloquin, MSc, Adam Gater, Verna L Welch, PhD MPH, Louise O'Hara, Ryan Hohman, Diana Merino, Nigel H. Russell, MD, Neil Horikoshi, Dawn Maze, MDFRCPC,MSc

Blood (2019) 134 (Supplement_1): 3498.

https://doi.org/10.1182/blood-2019-124660

Published: 2019

Journal Articles

Estimating the Relative Treatment Effect and Corresponding Cost-Effectiveness Estimates of Inotuzumab Ozogamicin Vs. Blinatumomab for Adults with Philadelphia Chromosome-Negative (Ph-) Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukaemia (B-ALL) in the United Kingdom (UK)

Simone Critchlow, Miranda Cooper, Ilse van Oostrum, Verna L Welch, PhD MPH, T. Alexander Russell-Smith

Blood (2019) 134 (Supplement_1): 3427.

https://doi.org/10.1182/blood-2019-123454

Published: 2019

Journal Articles

The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review

Tayler Scory, MSc, Eileen Shaw, MSc, Tara Cowling, MSc, Francois Peloquin, MSc, Verna L Welch, PhD MPH, Majed Charaan, MSc, MBA, Andrew Brown, PhD

Blood (2019) 134 (Supplement_1): 5829.

https://doi.org/10.1182/blood-2019-121814

Published: 2019

Journal Articles

Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) and Other High-Grade Myeloid Neoplasms

Anna B. Halpern, MD, Nicholas P Howard, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Nikita Vashi Baclig, MD MPH, Sarah A Buckley, MD, Mary-Elizabeth M. Percival, MD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Sioban B. Keel, MD, Johnnie Orozco, MD, Ryan D. Cassaday, MD, Andrei R Shustov, MD, Garrett Hartley, Verna L Welch, PhD MPH, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS

Blood (2019) 134 (Supplement_1): 1317.

https://doi.org/10.1182/blood-2019-124586

Published: 2019

Journal Articles

Comparative Analysis of Patterns of Infectious Complications of Outpatient Vs. Inpatient Care Following Intensive Induction Chemotherapy for Adults with Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasms

Anna B. Halpern, MD, Nicholas P Howard, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Nikita Vashi Baclig, MD MPH, Sarah A Buckley, MD, Mary-Elizabeth M. Percival, MD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Sioban Keel, MD, Johnnie Orozco, MD, Ryan D. Cassaday, MD, Andrei R Shustov, MD, Garrett Hartley, Verna L Welch, PhD MPH, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS

Blood (2019) 134 (Supplement_1): 1323.

https://doi.org/10.1182/blood-2019-123605

Published: 2019

Journal Articles

Treatment in AML and MDS Patients Who Are Ineligible for Intensive Chemotherapy: Using Social Media Intelligence to Capture What Really Matters to Patients

Alison Booth, MSc, Timothy J Bell, Sonia Halhol, MSc, Shiyu Pan, MSc, Verna L Welch, PhD MPH, CPEHR, CPHIMS, Evie Merinopoulou, MSc, Dimitra Lambrelli, PhD, Andrew Cox, PhD

Blood (2018) 132 (Supplement 1): 4826.

https://doi.org/10.1182/blood-2018-99-112827

Published: 2018

Journal Articles

Budget Impact of First-Line Bosutinib for Chronic Phase Chronic Myeloid Leukemia on a US Health Plan

Verna L Welch, PhD MPH, CPEHR, CPHIMS, Peter Quon, MPH, Denise Zou, Jennifer Uyei, PhD MPH, Sherry Wu, MPH, Ying Xiao, Carla M. Mamolo, PhD

Blood (2018) 132 (Supplement 1): 5834.

https://doi.org/10.1182/blood-2018-99-110544

Published: 2018

Journal Articles

Using Social Media to Highlight Unmet Needs in Patients with AML and MDS Ineligible for Intensive Chemotherapy: A Patient Centered Perspective

Alison Booth, MSc, Timothy J Bell, Sonia Halhol, MSc, Shiyu Pan, MSc, Verna L Welch, PhD MPH, CPEHR, CPHIMS, Evie Merinopoulou, MSc, Dimitra Lambrelli, PhD, Andrew Cox, PhD

Blood (2018) 132 (Supplement 1): 4831.

https://doi.org/10.1182/blood-2018-99-112922

Published: 2018

Journal Articles

A Patient-Centred Approach to Understanding the Trade-Offs Associated with Treatment Decision Making in Hematological Cancers with Short Life Expectancy

Chloe Johnson, Timothy J Bell, Kate Sully, PhD, Verna L Welch, PhD MPH, CPEHR, CPHIMS, Francois Peloquin, BS, Adam Gater

Blood (2018) 132 (Supplement 1): 5899.

https://doi.org/10.1182/blood-2018-99-116226

Published: 2018

NARROW

Patterns of Undertreatment Among Patients with Acute Myeloid Leukemia (AML) Not Receiving Standard Intensive Induction Chemotherapy

Treatment Decision Making in AML: Factors of Importance to Clinicians, AML Patients and Their Family

Estimating the Relative Treatment Effect and Corresponding Cost-Effectiveness Estimates of Inotuzumab Ozogamicin Vs. Blinatumomab for Adults with Philadelphia Chromosome-Negative (Ph-) Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukaemia (B-ALL) in the United Kingdom (UK)

The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review

Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) and Other High-Grade Myeloid Neoplasms

Comparative Analysis of Patterns of Infectious Complications of Outpatient Vs. Inpatient Care Following Intensive Induction Chemotherapy for Adults with Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasms

Treatment in AML and MDS Patients Who Are Ineligible for Intensive Chemotherapy: Using Social Media Intelligence to Capture What Really Matters to Patients

Budget Impact of First-Line Bosutinib for Chronic Phase Chronic Myeloid Leukemia on a US Health Plan

Using Social Media to Highlight Unmet Needs in Patients with AML and MDS Ineligible for Intensive Chemotherapy: A Patient Centered Perspective

A Patient-Centred Approach to Understanding the Trade-Offs Associated with Treatment Decision Making in Hematological Cancers with Short Life Expectancy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only